Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 4/2021

02.03.2021 | Maternal-Fetal Medicine

Second-trimester and third-trimester maternal lipid profiles significantly correlated to LGA and macrosomia

verfasst von: Fangfang Xi, Huiqi Chen, Qinqing Chen, Danqing Chen, Yuan Chen, Matthew Sagnelli, Guangdi Chen, Baihui Zhao, Qiong Luo

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 4/2021

Einloggen, um Zugang zu erhalten

Abstract

Background

According to the theory of fetal-derived adult diseases, abnormal fetal development might affect the occurrence of diseases in adulthood, and appropriate fetal growth status intrauterine might have a beneficial effect on it. To adapt properly for fetal development, there are numerous changes in the maternal physiology during pregnancy, including blood lipid metabolism. The aim of this study is to evaluate the association between lipid profiles in the second and third trimesters of normal pregnancy and fetal birth weight.

Materials and methods

The study population was derived from 5695 pregnant women, who maintained routine prenatal care at the women’s hospital of Zhejiang University, School of medicine January 1, 2014, and December 31, 2014. The pregnant women in this study all carried uncomplicated singleton pregnancies to at least 37 weeks.

Results

The mean (standard deviation) birth weight was 3361.00 (385.94) g; 413 (7.3%) of the infants were large for gestational age, and 330 (5.8%) were macrosomia. On multiple linear regression analysis, positive determinants of birth weight were gravidity, parity, gestational age at delivery, male infant, maternal height, and weight before pregnancy, weight gain during pregnancy, fasting blood glucose (FBG) level, second-trimester cholesterol (TC) and third-trimester triglyceride (TG), gestational albumin (ALB), and third-trimester high-density lipoprotein (HDL-C) levels were each negatively associated with birth weight. On logistic regression analysis, the significant metabolic lipid predictors of delivering a large-for-gestational-age infant were second- and third-trimester TG (aOR = 1.178, 95% CI 1.032–1.344, p = 0.015; aOR = 1.106, 95% CI 1.043–1.173, p = 0.001, respectively) and second- and third-trimester HDL-C level (aOR = 0.655, 95% CI 0.491–0.874, p = 0.004; aOR = 0.505, 95% CI 0.391–0.651, p < 0.001, respectively). Third-trimester TG and HDL-C were stable predictors of large-for-gestational-age infants in stratification analysis. High TG and low HDL-C level during third trimester could be considered as indicators of a high risk of large for gestational age (LGA) and macrosomia, regardless of infant gender.

Conclusion

These results suggest that future lifestyle programs in women of reproductive age with a focus on lowering TG levels (i.e., diet, weight reduction, and physical activity) may help to reduce the incidence of LGA and macrosomia.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Brizzi P, Tonolo G, Esposito F, Puddu L, Dessole S, Maioli M, Milia S (1999) Lipo-protein metabolism during normal pregnancy. Am J Obstet Gynecol 181(2):430CrossRef Brizzi P, Tonolo G, Esposito F, Puddu L, Dessole S, Maioli M, Milia S (1999) Lipo-protein metabolism during normal pregnancy. Am J Obstet Gynecol 181(2):430CrossRef
3.
Zurück zum Zitat Saarelainen H, Laitinen T, Raitakari OT, Juonala M, Heiskanen N, Lyyra-Laitinen T, Viikari JS, Vanninen E, Heinonen S (2006) Pregnancy-related hyperlipidemia and endothelial function in healthy women. Circ J 70(6):768–772CrossRef Saarelainen H, Laitinen T, Raitakari OT, Juonala M, Heiskanen N, Lyyra-Laitinen T, Viikari JS, Vanninen E, Heinonen S (2006) Pregnancy-related hyperlipidemia and endothelial function in healthy women. Circ J 70(6):768–772CrossRef
4.
Zurück zum Zitat Ryckman KK, Spracklen CN, Smith CJ, Robinson JG, Saftlas AF (2015) Maternal lipid levels during pregnancy and gestational diabetes: a systematic review and meta-analysis. BJOG 122(5):643–651CrossRef Ryckman KK, Spracklen CN, Smith CJ, Robinson JG, Saftlas AF (2015) Maternal lipid levels during pregnancy and gestational diabetes: a systematic review and meta-analysis. BJOG 122(5):643–651CrossRef
5.
Zurück zum Zitat Mankuta D, Elami-Suzin M, Elhayani A, Vinker S (2010) Lipid profile in consecutive pregnancies. Lipids Health Dis 5(9):58CrossRef Mankuta D, Elami-Suzin M, Elhayani A, Vinker S (2010) Lipid profile in consecutive pregnancies. Lipids Health Dis 5(9):58CrossRef
6.
Zurück zum Zitat Herrera E (2000) Metabolism adaptations in pregnancy and their implications for the availability of substrates to the fetus. Eur J Cin Nutr 5(4):47–51CrossRef Herrera E (2000) Metabolism adaptations in pregnancy and their implications for the availability of substrates to the fetus. Eur J Cin Nutr 5(4):47–51CrossRef
7.
Zurück zum Zitat Olmos PR, Rigotti A, Busso D, Berkowitz L, Santos JL, Borzone GR, Poblete JA, Vera C, Belmar C, Goldenberg D, Samith B, Acosta AM, Escalona M, Niklitschek I, Mandiola JR, Mertens N (2014) Maternal hypertriglyceridemia: A link between maternal overweight-obesity and macrosomia in gestational diabetes. Obesity 22(10):2156–2163CrossRef Olmos PR, Rigotti A, Busso D, Berkowitz L, Santos JL, Borzone GR, Poblete JA, Vera C, Belmar C, Goldenberg D, Samith B, Acosta AM, Escalona M, Niklitschek I, Mandiola JR, Mertens N (2014) Maternal hypertriglyceridemia: A link between maternal overweight-obesity and macrosomia in gestational diabetes. Obesity 22(10):2156–2163CrossRef
8.
Zurück zum Zitat Di Cianni G, Miccoli R, Volpe L, Lencioni C, Ghio A, Giovannitti MG, Cuccuru I, Pellegrini G, Chatzianagnostou K, Boldrini A, Del Prato S (2005) Maternal triglyceride levels and newborn weight in pregnant women with normal glucose tolerance. Diabet Med 22(1):21–25CrossRef Di Cianni G, Miccoli R, Volpe L, Lencioni C, Ghio A, Giovannitti MG, Cuccuru I, Pellegrini G, Chatzianagnostou K, Boldrini A, Del Prato S (2005) Maternal triglyceride levels and newborn weight in pregnant women with normal glucose tolerance. Diabet Med 22(1):21–25CrossRef
9.
Zurück zum Zitat Whyte K, Kelly H, O’ Dwyer V, Gibbs M, O’ Higgins A, Turner MJ (2013) Offspring birth weight and maternal fasting lipids in women screened for gestational diabetes mellitus (GDM). Eur J Obstet Gynecol Reprod Biol 170(1):67–70CrossRef Whyte K, Kelly H, O’ Dwyer V, Gibbs M, O’ Higgins A, Turner MJ (2013) Offspring birth weight and maternal fasting lipids in women screened for gestational diabetes mellitus (GDM). Eur J Obstet Gynecol Reprod Biol 170(1):67–70CrossRef
10.
Zurück zum Zitat Haugen AC, Schug TT, Collman G, Heindel JJ (2015) Evolution of DOHaD: the impact of environmental health sciences. J Dev Orig Health Dis 6(2):55–64CrossRef Haugen AC, Schug TT, Collman G, Heindel JJ (2015) Evolution of DOHaD: the impact of environmental health sciences. J Dev Orig Health Dis 6(2):55–64CrossRef
11.
Zurück zum Zitat Fleming TP, Velazquez MA, Eckert JJ (2015) Embryos, DOHaD and David Barker. J Dev Orig Health Dis 6(5):377–383CrossRef Fleming TP, Velazquez MA, Eckert JJ (2015) Embryos, DOHaD and David Barker. J Dev Orig Health Dis 6(5):377–383CrossRef
12.
Zurück zum Zitat Jin WY, Lin SL, Hou RL, Chen XY, Han T, Jin Y, Tang L, Zhu ZW, Zhao ZY (2016) Associations between maternal lipid profile and pregnancy complications and perinatal outcomes: a population-based study from China. BMC pregnancy and Childbirth 16(3):60–69CrossRef Jin WY, Lin SL, Hou RL, Chen XY, Han T, Jin Y, Tang L, Zhu ZW, Zhao ZY (2016) Associations between maternal lipid profile and pregnancy complications and perinatal outcomes: a population-based study from China. BMC pregnancy and Childbirth 16(3):60–69CrossRef
14.
Zurück zum Zitat Herrera E, Ortega-Senovilla H (2010) Disturbances in lipid metabolism in diabetic pregnancy—are these the cause of the problem? Best Pract Res Clin Endocrinol Metab 24(4):515–525CrossRef Herrera E, Ortega-Senovilla H (2010) Disturbances in lipid metabolism in diabetic pregnancy—are these the cause of the problem? Best Pract Res Clin Endocrinol Metab 24(4):515–525CrossRef
15.
Zurück zum Zitat Obesity: preventing and managing the global epidemic (2000) Report of a WHO consultation. World Health Organ Tech Rep Ser 894:i–253 Obesity: preventing and managing the global epidemic (2000) Report of a WHO consultation. World Health Organ Tech Rep Ser 894:i–253
16.
Zurück zum Zitat Rasmussen KM, Yaktine AL, et al (2009) Institute of Medicine (US) and National Research Council (US) Committee to Reexamine IOM Pregnancy Weight Guidelines. Weight Gain During Pregnancy: Reexamining the Guidelines. National Academies Press (US), Washington (DC) Rasmussen KM, Yaktine AL, et al (2009) Institute of Medicine (US) and National Research Council (US) Committee to Reexamine IOM Pregnancy Weight Guidelines. Weight Gain During Pregnancy: Reexamining the Guidelines. National Academies Press (US), Washington (DC)
18.
Zurück zum Zitat Li Z, Rong Z, Shulian Z et al (2015) Chinese neonatal birth weight curve for different gestational age. Chin J Pediatrics 53(2):97–103 Li Z, Rong Z, Shulian Z et al (2015) Chinese neonatal birth weight curve for different gestational age. Chin J Pediatrics 53(2):97–103
19.
Zurück zum Zitat HAPO Study Cooperative Research Group, Metzger BE, Lowe LP et al (2008) Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 358(19):1991–2002CrossRef HAPO Study Cooperative Research Group, Metzger BE, Lowe LP et al (2008) Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 358(19):1991–2002CrossRef
20.
Zurück zum Zitat HAPO Study Cooperative Research Group (2009) Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations with neonatal anthropometrics. Diabetes 58(2):453–459CrossRef HAPO Study Cooperative Research Group (2009) Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations with neonatal anthropometrics. Diabetes 58(2):453–459CrossRef
21.
Zurück zum Zitat Crume TL, Shapiro AL, Brinton JT et al (2015) Maternal fuels and metabolic measures during pregnancy and neonatal body composition: the healthy start study. J Clin Endocrinol Metab 100(4):1672–1680CrossRef Crume TL, Shapiro AL, Brinton JT et al (2015) Maternal fuels and metabolic measures during pregnancy and neonatal body composition: the healthy start study. J Clin Endocrinol Metab 100(4):1672–1680CrossRef
22.
Zurück zum Zitat Herrera E (2000) Metabolic adaptations in pregnancy and their implications for the availability of substrates to the fetus. Eur J Clin Nutr 54(Suppl 1):S47–S51CrossRef Herrera E (2000) Metabolic adaptations in pregnancy and their implications for the availability of substrates to the fetus. Eur J Clin Nutr 54(Suppl 1):S47–S51CrossRef
23.
Zurück zum Zitat Staat BC, Galan HL, Harwood JE et al (2012) Transplacental supply of mannose and inositol in uncomplicated pregnancies using stable isotopes. J Clin Endocrinol Metab 97(7):2497–2502CrossRef Staat BC, Galan HL, Harwood JE et al (2012) Transplacental supply of mannose and inositol in uncomplicated pregnancies using stable isotopes. J Clin Endocrinol Metab 97(7):2497–2502CrossRef
24.
Zurück zum Zitat Misra VK, Trudeau S, Perni U (2011) Maternal serum lipids during pregnancy and infant birth weight: the influence of prepregnancy BMI. Obesity (Silver Spring) 19(7):1476–1481CrossRef Misra VK, Trudeau S, Perni U (2011) Maternal serum lipids during pregnancy and infant birth weight: the influence of prepregnancy BMI. Obesity (Silver Spring) 19(7):1476–1481CrossRef
25.
Zurück zum Zitat Kulkarni SR, Kumaran K, Rao SR et al (2013) Maternal lipids are as important as glucose for fetal growth: findings from the Pune Maternal Nutrition Study. Diabetes Care 36(9):2706–2713CrossRef Kulkarni SR, Kumaran K, Rao SR et al (2013) Maternal lipids are as important as glucose for fetal growth: findings from the Pune Maternal Nutrition Study. Diabetes Care 36(9):2706–2713CrossRef
26.
Zurück zum Zitat Clausen T, Burski TK, Øyen N, Godang K, Bollerslev J, Henriksen T (2005) Maternal anthropometric and metabolic factors in the first half of pregnancy and risk of neonatal macrosomia in term pregnancies. A prospective study. Eur J Endocrinol 153(6):887–894CrossRef Clausen T, Burski TK, Øyen N, Godang K, Bollerslev J, Henriksen T (2005) Maternal anthropometric and metabolic factors in the first half of pregnancy and risk of neonatal macrosomia in term pregnancies. A prospective study. Eur J Endocrinol 153(6):887–894CrossRef
27.
Zurück zum Zitat Brown WV (2007) High-density lipoprotein and transport of cholesterol and triglyceride in blood. J Clin Lipidol 1(1):7–19CrossRef Brown WV (2007) High-density lipoprotein and transport of cholesterol and triglyceride in blood. J Clin Lipidol 1(1):7–19CrossRef
28.
Zurück zum Zitat Patsch W, Sharrett AR, Sorlie PD, Davis CE, Brown SA (1992) The relation of high density lipoprotein cholesterol and its subfractions to apolipoprotein A-I and fasting triglycerides: the role of environmental factors. The Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol 136(5):546–557CrossRef Patsch W, Sharrett AR, Sorlie PD, Davis CE, Brown SA (1992) The relation of high density lipoprotein cholesterol and its subfractions to apolipoprotein A-I and fasting triglycerides: the role of environmental factors. The Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol 136(5):546–557CrossRef
29.
Zurück zum Zitat Boghossian NS, Mendola P, Liu A, Robledo C, Yeung EH (2017) Maternal serum markers of lipid metabolism in relation to neonatal anthropometry. J Perinatol 37(6):629–635CrossRef Boghossian NS, Mendola P, Liu A, Robledo C, Yeung EH (2017) Maternal serum markers of lipid metabolism in relation to neonatal anthropometry. J Perinatol 37(6):629–635CrossRef
30.
Zurück zum Zitat Martineau MG, Raker C, Dixon PH et al (2015) The metabolic profile of intrahepatic cholestasis of pregnancy is associated with impaired glucose tolerance, dyslipidemia, and increased fetal growth. Diabetes Care 38(2):243–248CrossRef Martineau MG, Raker C, Dixon PH et al (2015) The metabolic profile of intrahepatic cholestasis of pregnancy is associated with impaired glucose tolerance, dyslipidemia, and increased fetal growth. Diabetes Care 38(2):243–248CrossRef
31.
Zurück zum Zitat Moayeri M, Heida KY, Franx A, Spiering W, de Laat MW, Oudijk MA (2017) Maternal lipid profile and the relation with spontaneous preterm delivery: a systematic review. Arch Gynecol Obstet 295(2):313–323CrossRef Moayeri M, Heida KY, Franx A, Spiering W, de Laat MW, Oudijk MA (2017) Maternal lipid profile and the relation with spontaneous preterm delivery: a systematic review. Arch Gynecol Obstet 295(2):313–323CrossRef
Metadaten
Titel
Second-trimester and third-trimester maternal lipid profiles significantly correlated to LGA and macrosomia
verfasst von
Fangfang Xi
Huiqi Chen
Qinqing Chen
Danqing Chen
Yuan Chen
Matthew Sagnelli
Guangdi Chen
Baihui Zhao
Qiong Luo
Publikationsdatum
02.03.2021
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 4/2021
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-021-06010-0

Weitere Artikel der Ausgabe 4/2021

Archives of Gynecology and Obstetrics 4/2021 Zur Ausgabe

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

Blutdrucksenkung könnte Uterusmyome verhindern

Frauen mit unbehandelter oder neu auftretender Hypertonie haben ein deutlich erhöhtes Risiko für Uterusmyome. Eine Therapie mit Antihypertensiva geht hingegen mit einer verringerten Inzidenz der gutartigen Tumoren einher.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.